English
This article is from North American Journal of Medical Sciences , volume 5 . Abstract Background:: Ankle edema is a common adverse effect of amlodipine, an L-type calcium channel blocker (CCB). Cilnidipine is a newer L/N-type CCB, approved for treatment of essential hypertension. Aim:: This study was designed to determine whether cilnidipine can produce resolution of amlodipine-induced edema while maintaining adequate control of hypertension. Materials and Methods:: A prospective study was performed on 27 patients with essential hypertension with amlodipine-induced edema. Concomitant nephropathy, cardiac failure, hepatic cirrhosis, or other causes of edema, and secondary hypertension were excluded by appropriate tests. Amlodipine therapy was substituted in all the cases with an efficacy-equivalent dose of cilnidipine. Clinical assessment of ankle edema and measurement of bilateral ankle circumference, body weight, blood pressure, and pulse rate were performed at onset of the study and after 4 weeks of cilnidipine therapy. Results:: At completion of the study, edema had resolved in all the patients. There was a significant decrease in bilateral ankle circumference and body weight (P
Sign in with your free account to read, download EPUBs or listen.
Ebook · Excellent Tolerance to Cilnidipine in Hypertensives with Amlodipine - Induced Edema. · Shetty, Ranjan, Vivek, G, Naha, Kushal, Tumkur, Anil, Raj, Abhinav, Bairy, K L · Internet Archive